Balanced news tone
News Sentiment
XFOR sentiment intelligence
X4 Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
82/100 classification confidence.
directly relevant articles
high-authority source matches
+6.8% over one week, +10.3% over four weeks, trend active, and below fair value.
X4 Pharmaceuticals (XFOR) Proxy filing Summary
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Bears are Losing Control Over X4 Pharmaceuticals (XFOR), Here's Why It's a 'Buy' Now
- Tone
- Positive 58/100
- Event
- Market update
- Published
- 20 May 2026 13:55
- Source
- Zacks
How The X4 Pharmaceuticals (XFOR) Story Is Shifting With Mavorixafor And New EU Progress
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 May 2026 07:00
- Source
- Market source
X4 Pharmaceuticals (XFOR) Upgraded to Buy: Here's What You Should Know
- Tone
- Positive 84/100
- Event
- Analyst action
- Published
- 18 May 2026 07:00
- Source
- Market source
This Insider Has Just Sold Shares In X4 Pharmaceuticals
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Here is Why X4 Pharmaceuticals (XFOR) is Among the Unrivaled Penny Stocks to Buy Now
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 14 May 2026 07:00
- Source
- Market source
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
X4 Pharmaceuticals (XFOR) CFO sells shares to cover tax obligation
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 May 2026 07:00
- Source
- Stock Titan
[144] X4 Pharmaceuticals, Inc SEC Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 07:00
- Source
- Stock Titan
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
X4 Pharmaceuticals: Q1 Earnings Snapshot
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 May 2026 11:26
- Source
- Associated Press
X4 Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 May 2026 07:00
- Source
- GlobeNewswire
X4 Pharmaceuticals (XFOR) Reports Q1 Loss, Lags Revenue Estimates
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 06 May 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
X4 Pharmaceuticals, Inc. Common Stock (XFOR) Stock Price Today & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jan 2026 21:26
- Source
- Gotrade
X4 Pharmaceuticals Announces $60 Million Equity Financing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Aug 2025 07:00
- Source
- GlobeNewswire
XFOR SEC Filings - X4 Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2025 02:16
- Source
- Stock Titan
X4 Pharmaceuticals (XFOR) Stock Price, News & Analysis $XFOR
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2019 00:14
- Source
- MarketBeat